Treatment of hypertension: A failing report card

American Journal of Hypertension

Volumn 22, Issue 1, 2009, Pages 1-2

  Furberg, Curt D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; RENIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; HUMAN; HYPERTENSION; MONOTHERAPY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; BIOMEDICAL RESEARCH; BLOOD PRESSURE; DOCUMENTATION; HUMANS; HYPERTENSION;

EID: 57749177518     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.324     Document Type: Editorial

References (5)

1. Alderman MH. Mild hypertension: New light on an old clinical controversy. Am J Med 1980; 69: 653-655.
2. Sealey JE, Laragh JH. Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises. Am J Hypertens 2009; 22:112-121.
3. Laragh JH, Egan BM, Sealey JE, Lackland DT, Basile JN, Rehman SU, Strange P, Grob C, Riehle J, Walters C. A randomized controlled trial of the Laragh method, a plasma renin test guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension. J Hypertens 2008;26 (Suppl I):S470. (Abstract).
4. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM; American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Resarch. Circulation 2008; 117: e510-e526.
5. Cushman WC, Ford CE, Einhorn PT, Wright JT, Preston RA, Davis BR, Basile JN, Whelton PK, Weiss RJ, Bastien A, Courtney DL, Hamilton BP, Kirchner K, Louis GT, Retta TM, Vidt DG; ALLHAT Collaborative Research Group. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2008; 10: 1-11.